All three classes of medication were associated with a reduced risk of type 2 diabetes when used at bedtime, the researchers found. This could be an essential study, which would impact how exactly we treat high blood pressure in people who have people and diabetes at risk for diabetes, Bloomgarden said. These are some really interesting observations you can match together into this notion that something’s especially going on at night. After showing that reduced blood pressure during sleep was associated with lower risk of type 2 diabetes, the researchers made a decision to see whether taking an entire daily dose of 1 or more blood pressure medications at bedtime could drive a person’s type 2 diabetes risk down a lot more.‘We’re trying to figure out how cancerous and noncancerous cells communicate with one another, how they bind to each other, and what the results of those interactions are,’ Ligon said. THE STUDY Scholar Grant from the American Cancer Society includes a four-year $720,000 award to support this extensive research. ‘The Research Scholar Grant is an extremely prestigious award for junior faculty. This grant acknowledges the need for Dr. Ligon’s function in neuro-scientific cancer research and heralds a promising upcoming of valuable insights and discoveries,’ stated Susan Gilbert, a Rensselaer head and professor of the section of biology.